NANO Nuclear Energy Inc.

NASDAQ•NNE

CEO: Mr. Jiang Yu

Sector: Industrials

Industry: Industrial - Machinery

Listing Date: 2000-01-05

NANO Nuclear Energy Inc. operates as a microreactor technology company. The company is developing ZEUS, a solid-core battery reactor, and ODIN, a low-pressure coolant reactor. It is also developing a high-assay low-enriched uranium fabrication facility to supply fuel to the nuclear reactor industry and fuel transportation and nuclear consultation businesses. The company was founded in 2021 and is based in New York, New York.

Contact Information

10 Times Square, 30th Floor, New York, NY, 10018, United States

212-634-9206

nanonuclearenergy.com

Market Cap

$1.07B

P/E (TTM)

-29.6

21.4

Dividend Yield

52W High

$60.87

52W Low

$17.26

52W Range

20%

Rank59Top 87.6%

2.2

F-Score

Modified Piotroski Analysis

Based on 4-year fundamentals

Weak • 2.2 / 9 points

Scoring Range (0-9)

8-9: Excellent Value

6-7: Strong Fundamentals

4-5: Average Quality

0-3: Weak Performance

Data Period: 2022-2025

Financial Dashboard

Q1 2026 Data

Revenue

$0.00+0.00%

4-Quarter Trend

EPS

-$0.13+0.00%

4-Quarter Trend

FCF

-$3.99B+0.00%

4-Quarter Trend

2026 Q1 Earnings Highlights

Key Highlights

Strong Financing Inflow Net cash from financing $381.33M USD; October 2025 private placement raised $400.00M gross USD.

R&D Spending Accelerates R&D expense $5.40M USD for three months, up 497% versus prior period's $0.90M USD spend.

Cash Position Strengthened Cash equivalents reached $577.53M USD December 31, 2025; working capital $576.43M USD.

Reactor Licensing Progress NRC approved Fuel Qualification Methodology Topical Report; targeting construction permit submission first half 2026.

Risk Factors

Future Funding Uncertainty Future capital needs require equity/debt financing; inability to raise funds could materially affect operations failure.

Regulatory Timeline Risks KRONOS reactor licensing timeline uncertain; NRC review timing outside management control, potentially delaying commercialization.

Operating Loss Widening Net loss $6.52M USD for quarter, nearly doubling prior period's $3.11M USD loss; cash used in operations $3.99M USD.

SEC Investigation Ongoing Received subpoena regarding two service providers; cannot predict outcome of SEC investigation initiated April 2025.

Outlook

KRONOS Commercialization Target Aiming for NRC construction permit submission first half 2026; initial operation projected between 2030 and 2031.

Illinois Facility Investment Plan investment over $12M USD in Illinois facility for manufacturing and R&D; expecting $6.8M USD in incentives.

Consulting Revenue Near Term Generating small consulting revenue in 2025; formal launch dependent on acquiring existing revenue-generating businesses.

ODINT Reactor Sale Considered Signed Letter of Intent for proposed sale of ODINT microreactor design to monetize investment and focus resources.

Peer Comparison

Revenue (TTM)

ZIM

$6.90B

-18.1%

$2.52B

-19.2%

ENOV

$2.25B

+6.7%

Gross Margin (Latest Quarter)

ENOV

60.7%

+3.2pp

EPAC

45.4%

-1.8pp

SXI

39.7%

+2.0pp

Key Metrics

Symbol	Market Cap	P/E (TTM)	ROE (TTM)	Debt to Assets
SXI	$3.37B	62.2	7.7%	40.1%
ZIM	$3.25B	6.8	12.1%	52.1%
ATS	$3.21B	232.7	1.1%	35.6%

Long-Term Trends

Last 4 Quarters

Revenue

Net Income

Operating Cash Flow

4Q Revenue CAGR

N/M

Revenue Volatile

4Q Net Income CAGR

N/M

Profitability Shift

Cash Flow Stability

Cash Flow Needs Attention

Deep Research

Next earnings:May 13, 2026

EPS:-

Revenue:-

Financials

Earnings Calls

Reports

News

Income Statement

Balance Sheet

Cash Flow Statement

Ratios

% Chg.

Income Statement	LTM

No Data